The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Amgen (I)
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Novartis; OncLive; Pfizer; Xcenda
Research Funding - Acceleron Pharma; Agensys; Bayer; Bristol-Myers Squibb; Novartis; Pfizer
 
Honoraria - Bristol-Myers Squibb (I); MSD (I); Novartis (I); Pfizer (I); Roche (I)
Consulting or Advisory Role - Bristol-Myers Squibb (I); MSD (I); Novartis (I); Pfizer (I); Roche (I)
Speakers' Bureau - Bristol-Myers Squibb (I); MSD (I); Novartis (I); Pfizer (I); Roche (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I); MSD (I)
Treatment beyond progression with nivolumab (nivo) in patients (pts) with advanced renal cell carcinoma (aRCC) in the phase III CheckMate 025 study.
 
Bernard J. Escudier
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Novartis; Pfizer
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Padmanee Sharma
Stock and Other Ownership Interests - Jounce Therapeutics; Kite, a Gilead company
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Jounce Therapeutics; Kite, a Gilead company
 
John Wagstaff
No Relationships to Disclose
 
Elizabeth R. Plimack
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - Acceleron Pharma (Inst); Acerta Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - U.S. Patent No.: 14/588,503, Filed 1/2/2015. (Inst)
 
Hans J. Hammers
Consulting or Advisory Role - Bristol-Myers Squibb; exelixis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Newlink Genetics (Inst); Pfizer (Inst); SFJ Pharmaceuticals Group (Inst); TRACON Pharma (Inst)
 
Frede Donskov
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
 
Howard Gurney
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer
 
Jeffrey Alan Sosman
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Novartis (Inst)
 
Pawel Zalewski
Consulting or Advisory Role - Astellas Pharma; Novartis; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Roche (Inst)
 
Ulrika Harmenberg
Leadership - Glionova (I); Medivir (I); Oncopeptides (I)
Stock and Other Ownership Interests - Akinion (I); Axelar (I); Medivir (I); Oncopeptides (I); OxyPharma (I)
Consulting or Advisory Role - Glionova (I); Medivir (I); Oncopeptides (I)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Oncopeptides (I)
 
David F. McDermott
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Martin Eduardo Richardet
No Relationships to Disclose
 
Yoshihiko Tomita
Honoraria - Pfizer
Consulting or Advisory Role - Novartis; Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Takeda (Inst)
 
Alain Ravaud
Honoraria - MSD; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Roche
Research Funding - Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Justin Doan
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Huanyu Zhao
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Helene Hardy
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Saby George
No Relationships to Disclose